Based on the CERENO SCIENTIFIC AB B stock forecast from 0 analysts, the average analyst target price for CERENO SCIENTIFIC AB B is not available over the next 12 months. CERENO SCIENTIFIC AB B’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CERENO SCIENTIFIC AB B is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, CERENO SCIENTIFIC AB B’s stock price was EUR 0.46. CERENO SCIENTIFIC AB B’s stock price has changed by -12.43% over the past week, +11.92% over the past month and +16.51% over the last year.
No recent analyst target price found for CERENO SCIENTIFIC AB B
No recent average analyst rating found for CERENO SCIENTIFIC AB B
Company Overview CERENO SCIENTIFIC AB B
Cereno Scientific AB (publ), clinical stage biotechnology company, develops therapeutics to treat cardiovascular and rare diseases worldwide. The company's lead drug candidate is CS1, a product candidate that is in phase II clinical trial for the treatment of rare disease pulmonary arterial hypertension, as well as a histone deacetylase (HDAC) inhibitor that acts as an epigenetic modulator with pressure-reducing, reverse-remodeling, anti-inflammatory, anti-fibrotic, and antithrombotic properties. Its preclinical drug candidates comprise CS585 and CS014 that is in pre clinical stage for the treatment of cardiovascular diseases. The company has a collaboration agreement with the University of Michigan for the preclinical development program of CS585 and CS014, are preclinical drug candidate for cardiovascular diseases; and Abbott for use of CardioMEMS HF System, as well as collaboration with the Pulmonary and Vascular Research Institute (PVRI). Cereno Scientific AB (publ) was founded in 2012 and is headquartered in Gothenburg, Sweden. Read Less
Cereno Scientific AB (publ), clinical stage biotechnology company, develops therapeutics to treat cardiovascular and rare diseases worldwide. The company's lead drug candidate is CS1, a product candidate that is in phase II clinical trial for the treatment of rare disease pulmona...Read More
Frequently Asked Questions About CERENO SCIENTIFIC AB B (4A1:F) Stock
Stock Target Advisor's fundamental analysis for CERENO SCIENTIFIC AB B's stock is Bearish.
Unfortunately we do not have enough data on 4A1:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4A1:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4A1:F's stock to indicate if its overvalued.
The last closing price of 4A1:F's stock was EUR 0.46.
The most recent market capitalization for 4A1:F is EUR 0.12B.
Unfortunately we do not have enough analyst data on 4A1:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CERENO SCIENTIFIC AB B's stock.
As per our most recent records CERENO SCIENTIFIC AB B has 5 Employees.
CERENO SCIENTIFIC AB B's registered address is BioVentureHub, Gothenburg, Sweden, 431 83.
You can get more information about it from CERENO SCIENTIFIC AB B's website at https://www.cerenoscientific.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About CERENO SCIENTIFIC AB B (4A1:F) Stock
Stock Target Advisor's fundamental analysis for CERENO SCIENTIFIC AB B's stock is Bearish.
Unfortunately we do not have enough data on 4A1:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4A1:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4A1:F's stock to indicate if its overvalued.
The last closing price of 4A1:F's stock was EUR 0.46.
The most recent market capitalization for 4A1:F is EUR 0.12B.
Unfortunately we do not have enough analyst data on 4A1:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CERENO SCIENTIFIC AB B's stock.
As per our most recent records CERENO SCIENTIFIC AB B has 5 Employees.
CERENO SCIENTIFIC AB B's registered address is BioVentureHub, Gothenburg, Sweden, 431 83.
You can get more information about it from CERENO SCIENTIFIC AB B's website at https://www.cerenoscientific.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4A1:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
